Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids
NCT01733147
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Barrett's Esophagus
Obesity
Interventions
DRUG:
Omega-3 polyunsaturated fatty acids
DRUG:
Placebo
Sponsor
Mayo Clinic